Can Alpha-Pinene Prevent Methotrexate-Induced Cardiac and Hepatic Damage?

. 2024 Aug 31 ; 73 (4) : 621-631.

Jazyk angličtina Země Česko Médium print

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/pmid39264082

The effects of alpha-pinene (AP), a monoterpenoid, known for its antioxidant, anti-inflammatory, and anti-apoptotic properties, on methotrexate (MTX)-induced cardiac and hepatic damage were investigated in this study. Male Sprague-Dawley rats were divided into Control, Vehicle, AP, MTX, and AP+MTX groups (n=7). AP (50 mg/kg/day, 14 days) was applied subcutaneously in the AP and AP+MTX groups. MTX (20 mg/kg) was injected three days before sacrification. Serum CK-MB, troponin T, ALT, and AST levels, as well as cardiac and hepatic MDA, GSH, caspase-3, and p53 levels, were measured by ELISA. Histological changes in tissues were evaluated by scoring in terms of tissue damage and cellular degeneration parameters after hematoxylin-eosin staining. MTX caused significant increase in serum CK-MB, troponin T, ALT, and AST levels, hepatic and cardiac lipid peroxidation, GSH depletion, and caspase-3 level. However, tissue levels of p53 did not change significantly. MTX-induced histological deterioration was observed in both tissues. These MTX-induced changes were significantly reduced in the AP+MTX group. Present results show that MTX-induced cardiac and hepatic damage is prevented by AP pretreatment. This protection can be attributed to the antioxidant and anti-apoptotic properties of AP. Considering the importance of MTX in cancer treatment, AP appears to have highly promising potential as a cardioprotective and hepatoprotective agent in anti-tumoral therapy. Key words: MDA, GSH, Caspase-3, p53, Oxidative stress, Apoptosis.

Zobrazit více v PubMed

Bedoui Y, Guillot X, Sélambarom J, Guiraud P, Giry C, Jaffar-Bandjee MC, Ralandison S, Gasque P. Methotrexate an old drug with new tricks. Int J Mol Sci. 2019;20(20):5023. doi: 10.3390/ijms20205023. PubMed DOI PMC

Cronstein BN. Low-dose methotrexate: a mainstay in the treatment of rheumatoid arthritis. Pharmacol Rev. 2005;57(2):163–172. doi: 10.1124/pr.57.2.3. PubMed DOI

Al-Abkal F, Abdel-Wahab BA, El-Kareem HFA, Moustafa YM, Khodeer DM. Protective effect of pycnogenol against methotrexate-induced hepatic, renal, and cardiac toxicity: an in vivo study. Pharmaceuticals (Basel) 2022;15(6):674. doi: 10.3390/ph15060674. PubMed DOI PMC

Abdel-Daim MM, Khalifa HA, Abushouk AI, Dkhil MA, Al-Quraishy SA. Diosmin attenuates methotrexate-induced hepatic, renal, and cardiac injury: a biochemical and histopathological study in mice. Oxid Med Cell Longev. 2017;2017:3281670. doi: 10.1155/2017/3281670. PubMed DOI PMC

Al-Taher AY, Morsy MA, Rifaai RA, Zenhom NM, Abdel-Gaber SA. Paeonol attenuates methotrexate-induced cardiac toxicity in rats by inhibiting oxidative stress and suppressing TLR4-induced NF-κB inflammatory pathway. Mediators Inflamm. 2020;2020:8641026. doi: 10.1155/2020/8641026. PubMed DOI PMC

Vezmar S, Becker A, Bode U, Jaehde U. Biochemical and clinical aspects of methotrexate neurotoxicity. Chemotherapy. 2003;49(1–2):92–104. doi: 10.1159/000069773. PubMed DOI

Brazdilova K, Koller T, Killinger Z, Payer J. Prevalence and risk factors for drug-induced liver injury among patients with rheumatic diseases treated with biological therapy: a single-center experience. Physiol Res. 2019;68(Suppl 2):S157–S163. doi: 10.33549/physiolres.934299. PubMed DOI

Ortega-Alonso A, Andrade RJ. Chronic liver injury induced by drugs and toxins. J Dig Dis. 2028;19(9):514–521. doi: 10.1111/1751-2980.12612. PubMed DOI

Jahovic N, Cevik H, Sehirli AO, Yeğen BC, Sener G. Melatonin prevents methotrexate-induced hepatorenal oxidative injury in rats. J Pineal Res. 2003;34(4):282–287. doi: 10.1034/j.1600-079X.2003.00043.x. PubMed DOI

Erdogan E, Ilgaz Y, Gurgor PN, Oztas Y, Topal T, Oztas E. Rutin ameliorates methotrexate induced hepatic injury in rats. Acta Cir Bras. 2015;30(11):778–784. doi: 10.1590/S0102-865020150110000009. PubMed DOI

Rizk FH, Saadany AAE, Dawood L, Elkaliny HH, Sarhan NI, Badawi R, Abd-Elsalam S. Metformin ameliorated methotrexate-induced hepatorenal toxicity in rats in addition to its antitumor activity: two birds with one stone. J Inflamm Res. 2018;11:421–429. doi: 10.2147/JIR.S178767. PubMed DOI PMC

Vespermann KA, Paulino BN, Barcelos MC, Pessôa MG, Pastore GM, Molina G. Biotransformation of α- and β-pinene into flavor compounds. Appl Microbiol Biotechnol. 2017;101(5):1805–1817. doi: 10.1007/s00253-016-8066-7. PubMed DOI

Karthikeyan R, Kanimozhi G, Prasad NR, Agilan B, Ganesan M, Srithar G. Alpha pinene modulates UVA-induced oxidative stress, DNA damage and apoptosis in human skin epidermal keratinocytes. Life Sci. 2018;212:150–158. doi: 10.1016/j.lfs.2018.10.004. PubMed DOI

Bouzenna H, Hfaiedh N, Giroux-Metges MA, Elfeki A, Talarmin H. Potential protective effects of alpha-pinene against cytotoxicity caused by aspirin in the IEC-6 cells. Biomed Pharmacother. 2017;93:961–968. doi: 10.1016/j.biopha.2017.06.031. PubMed DOI

Hou J, Zhang Y, Zhu Y, Zhou B, Ren C, Liang S, Guo Y. α-Pinene induces apoptotic cell death via caspase activation in human ovarian cancer cells. Med Sci Monit. 2019;25:6631–6638. doi: 10.12659/MSM.916419. PubMed DOI PMC

Chen WQ, Xu B, Mao JW, Wei FX, Li M, Liu T, Jin XB, Zhang LR. Inhibitory effects of α-pinene on hepatoma carcinoma cell proliferation. Asian Pac J Cancer Prev. 2014;15(7):3293–3297. doi: 10.7314/APJCP.2014.15.7.3293. PubMed DOI

Kim DS, Lee HJ, Jeon YD, Han YH, Kee JY, Kim HJ, Shin HJ, Kang J, Lee BS, Kim SH, Kim SJ, Park SH, Choi BM, Park SJ, Um JY, Hong SH. Alpha-pinene exhibits anti-inflammatory activity through the suppression of mapks and the nf-κb pathway in mouse peritoneal macrophages. Am J Chin Med. 2015;43(4):731–742. doi: 10.1142/S0192415X15500457. PubMed DOI

Allenspach M, Steuer C. α-Pinene: A never-ending story. Phytochemistry. 2021;190:112857. doi: 10.1016/j.phytochem.2021.112857. PubMed DOI

Rahmani H, Moloudi MR, Hashemi P, Hassanzadeh K, Izadpanah E. Alpha-pinene alleviates motor activity in animal model of Huntington’s disease via enhancing antioxidant capacity. Neurochem Res. 2023;48(6):1775–1782. doi: 10.1007/s11064-023-03860-9. PubMed DOI

Khan-Mohammadi-Khorrami MK, Asle-Rousta M, Rahnema M, Amini R. Neuroprotective effect of alpha-pinene is mediated by suppression of the TNF-α/NF-κB pathway in Alzheimer’s disease rat model. J Biochem Mol Toxicol. 2022;36(5):e23006. doi: 10.1002/jbt.23006. PubMed DOI

Khoshnazar M, Parvardeh S, Bigdeli MR. Alpha-pinene exerts neuroprotective effects via anti-inflammatory and anti-apoptotic mechanisms in a rat model of focal cerebral ischemia-reperfusion. J Stroke Cerebrovasc Dis. 2020;29(8):104977. doi: 10.1016/j.jstrokecerebrovasdis.2020.104977. PubMed DOI

Lee GY, Lee C, Park GH, Jang JH. Amelioration of scopolamine-induced learning and memory impairment by α-Pinene in C57BL/6 mice. Evid Based Complement Alternat Med. 2017;2017:4926815. doi: 10.1155/2017/4926815. PubMed DOI PMC

Rahimi K, Shirvani N, Sanaie P, Javadi A, Khademi M. The effects of alpha-pinene on the Nrf2-HO1 signaling pathway in gastric damage in rats. Mol Biol Rep. 2023;50(10):8615–8622. doi: 10.1007/s11033-023-08765-y. PubMed DOI

Demir S, Mentese A, Usta ZT, Alemdar NT, Demir EA, Aliyazicioglu Y. Alpha-pinene neutralizes cisplatin-induced reproductive toxicity in male rats through activation of Nrf2 pathway. Int Urol Nephrol. 2024;56(2):527–537. doi: 10.1007/s11255-023-03817-5. PubMed DOI

Zhang B, Wang H, Yang Z, Cao M, Wang K, Wang G, Zhao Y. Protective effect of alpha-pinene against isoproterenol-induced myocardial infarction through NF-κB signaling pathway. Hum Exp Toxicol. 2020;39(12):1596–1606. doi: 10.1177/0960327120934537. PubMed DOI

El-Sheikh AA, Morsy MA, Abdalla AM, Hamouda AH, Alhaider IA. Mechanisms of thymoquinone hepatorenal protection in methotrexate-induced toxicity in rats. Mediators Inflamm. 2015;2015:859383. doi: 10.1155/2015/859383. PubMed DOI PMC

Elmore S. Apoptosis: a review of programmed cell death. Toxicol Pathol. 2007;35(4):495–516. doi: 10.1080/01926230701320337. PubMed DOI PMC

Marin GE, Neag MA, Burlacu CC, Buzoianu AD. The protective effects of nutraceutical components in methotrexate-induced toxicity models-an overview. Microorganisms. 2022;10(10):2053. doi: 10.3390/microorganisms10102053. PubMed DOI PMC

Rašković A, Milanović I, Pavlović N, Ćebović T, Vukmirović S, Mikov M. Antioxidant activity of rosemary (Rosmarinus officinalis L.) essential oil and its hepatoprotective potential. BMC Complement Altern Med. 2014;14:225. doi: 10.1186/1472-6882-14-225. PubMed DOI PMC

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...